Kamen Efrem

CIK 00017891934 companiesNEW YORK, NY

SEC Profile

Transactions

Companies

Filings

CIK

0001789193

Recent Transactions

50 trades

Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2023-04-05$0.30/sh+663,000→ 8,090,202 total
Other
Insight Molecular Diagnostics Inc.$IMDX
Warrant to purchase common stock
2023-03-06−440,964→ 517,245 total
Other
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2023-03-06−3,890,111→ 4,589,571 total
Other
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2023-03-06−3,890,111→ 4,589,571 total
Sale
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2022-06-24$1.03/sh−40,464→ 8,479,682 total
Sale
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2022-06-24$1.05/sh−12,517→ 8,520,146 total
Sale
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2022-06-24$1.03/sh−35,441→ 7,427,202 total
Sale
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2022-06-24$1.05/sh−10,964→ 7,462,643 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Warrant to purchase common stock
2022-04-14+690,719→ 690,719 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2022-04-14$1.33/sh+1,665,898→ 7,350,447 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2022-04-14$1.26/sh+57,630→ 8,532,663 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Warrant to purchase common stock
2022-04-14+690,719→ 690,719 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2022-04-14$1.26/sh+57,630→ 8,532,663 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Warrant to purchase common stock
2022-04-14+958,209→ 958,209 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2022-04-14$1.23/sh+19,210→ 8,475,033 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2022-04-14$1.23/sh+19,210→ 8,475,033 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Warrant to purchase common stock
2022-04-14+832,949→ 832,949 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2022-04-14$1.26/sh+92,370→ 7,473,607 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2022-04-14$1.33/sh+1,381,438→ 1,381,438 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Warrant to purchase common stock
2022-04-14+383,976→ 383,976 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2022-04-14$1.33/sh+1,381,438→ 1,381,438 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Warrant to purchase common stock
2022-04-14+832,949→ 832,949 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2022-04-14$1.23/sh+30,790→ 7,381,237 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2022-04-14$1.33/sh+767,952→ 767,952 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2022-04-14$1.26/sh+92,370→ 7,473,607 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2022-04-14$1.33/sh+1,916,419→ 8,455,823 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2022-04-14$1.33/sh+767,952→ 767,952 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Warrant to purchase common stock
2022-04-14+383,976→ 383,976 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2022-04-14$1.23/sh+19,210→ 8,475,033 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Warrant to purchase common stock
2022-04-14+958,209→ 958,209 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2022-04-14$1.23/sh+30,790→ 7,381,237 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2022-04-14$1.26/sh+57,630→ 8,532,663 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2022-04-14$1.23/sh+30,790→ 7,381,237 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2022-04-14$1.33/sh+1,916,419→ 8,455,823 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2022-04-14$1.26/sh+92,370→ 7,473,607 total
Purchase
Insight Molecular Diagnostics Inc.$IMDX
Common Stock
2022-04-14$1.33/sh+1,665,898→ 7,350,447 total
Purchase
STRYVE FOODS, INC.$SNAX
Prepaid Common Stock Purchase Warrant (right to buy)
2021-09-15+800,000→ 800,000 total
Sale
STRYVE FOODS, INC.$SNAX
Class A Common Stock
2021-09-15−800,000→ 450,000 total
Other
MedMen Enterprises, Inc.
Senior Secured Convertible Note
2021-08-17
Other
MedMen Enterprises, Inc.
Senior Secured Convertible Note
2021-08-17
Other
MedMen Enterprises, Inc.
Senior Secured Convertible Note
2021-08-17
Other
MedMen Enterprises, Inc.
Senior Secured Convertible Note
2021-08-17
Other
MedMen Enterprises, Inc.
Warrant
2021-08-17−128,279→ 69,074 total
Other
MedMen Enterprises, Inc.
Senior Secured Convertible Note
2021-08-17
Other
MedMen Enterprises, Inc.
Senior Secured Convertible Note
2021-08-17
Other
MedMen Enterprises, Inc.
Senior Secured Convertible Note
2021-08-17
Other
MedMen Enterprises, Inc.
Warrant
2021-08-17−435,971→ 234,753 total
Other
MedMen Enterprises, Inc.
Warrant
2021-08-17−50,625→ 27,259 total
Other
MedMen Enterprises, Inc.
Warrant
2021-08-17−125,947→ 67,818 total
Other
MedMen Enterprises, Inc.
Senior Secured Convertible Note
2021-08-17

Companies

Recent Filings

Address

C/O PURA VIDA INVESTMENTS, LLC 150 EAST 52ND STREET, SUITE 32001

NEW YORK, NY, 10022

View on SEC.gov